Back
Sage Therapeutics Stock Price Chart
Sponsored
SAGE
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
23
SAGE
Sage Therapeutics
Last Price:
5.82
Seasonality Move:
19.95%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing slight buying pressure.
Sage Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.39 | Sell |
20-day SMA: | 7.12 | Sell |
50-day SMA: | 7.41 | Sell |
200-day SMA: | 13.47 | Sell |
8-day EMA: | 7.01 | Sell |
20-day EMA: | 7.21 | Sell |
50-day EMA: | 7.69 | Sell |
200-day EMA: | 13.06 | Sell |
Sage Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 34.79 | Sell |
Chaikin Money Flow: | 342651 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.43 - 7.79) | Sell |
Bollinger Bands (100): | (7.06 - 10.8) | Sell |
Sage Therapeutics Technical Analysis
Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sage Therapeutics Stock
Is Sage Therapeutics Stock a Buy?
- Sage Therapeutics share price is 6.05 while SAGE 8-day simple moving average is 7.39, which is a Sell signal.
- The stock price of SAGE is 6.05 while Sage Therapeutics 20-day SMA is 7.12, which makes it a Sell.
- Sage Therapeutics 50-day simple moving average is 7.41 while SAGE share price is 6.05, making it a Sell technically.
- SAGE stock price is 6.05 and Sage Therapeutics 200-day simple moving average is 13.47, creating a Sell signal.
SAGE Technical Analysis vs Fundamental Analysis
Sell
23
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy or a Sell?
-
Sage Therapeutics stock is rated a Sell
The current Sage Therapeutics [SAGE] share price is $6.05. The Score for SAGE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Sage Therapeutics Stock Info
Market Cap:
370.1M
Price in USD:
6.05
Share Volume:
1.06M
Sage Therapeutics 52-Week Range
52-Week High:
28.26
52-Week Low:
5.84
Sell
23
Sage Therapeutics (SAGE)
is a Sell
Sage Therapeutics Share Price Forecast
-
What is the Sage Therapeutics stock price today?
The Sage Therapeutics stock price is 6.05 USD today. -
Will SAGE stock go up or go down?
Sage Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sage Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sage Therapeutics is overvalued.
Is Sage Therapeutics Stock a Buy?
- Sage Therapeutics share price is 6.05 while SAGE 8-day exponential moving average is 7.01, which is a Sell signal.
- The stock price of SAGE is 6.05 while Sage Therapeutics 20-day EMA is 7.21, which makes it a Sell.
- Sage Therapeutics 50-day exponential moving average is 7.69 while SAGE share price is 6.05, making it a Sell technically.
- SAGE stock price is 6.05 and Sage Therapeutics 200-day simple moving average is 13.06, creating a Sell signal.
Fundamental Analysis of Sage Therapeutics
Is Sage Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.15 per share, and an increase next year of $2.10 per share.
Technical Analysis of Sage Therapeutics
Should I short Sage Therapeutics stock?
- SAGE Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Sage Therapeutics is a Sell
- Sage Therapeutics Relative Strength Index (RSI) is 34.79, which suggest Sage Therapeutics is oversold
- The Bollinger Bands (25) for Sage Therapeutics is (6.43 - 7.79), which suggest Sage Therapeutics is a Sell
- The Bollinger Bands (100) for Sage Therapeutics is (7.06 - 10.8), which suggest Sage Therapeutics is a Sell
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.